William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 62,920 shares at $47.37 ($3.0M) on 2019-05-09, disclosed to the SEC on 2019-05-10.
Open-market sale of $3.0M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.37 | 31,460 | $1.5M | 50.0% |
| 2 | $47.37 | 31,460 | $1.5M | 50.0% |
| Total | $47.37 avg | 62,920 | $3.0M | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |